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DESTABILIZATION OF THE MEDIAL MENISCUS AS A MODEL FOR THE
STUDY OF PAIN PATHWAYS ASSOCIATEDWITH DEVELOPMENT OF
MURINE OSTEOARTHRITIS
R. Das1, A. Plaas1, J.D. Sandy1, M.D. Tortorella2, A.-M. Malfait1
1Rush Univ. Med. Ctr., Chicago, IL; 2Guangzhou Inst. of BioMed. Hlth.,
Guangzhou, China
Purpose: Pain is the major symptom in osteoarthritis (OA) and one of
the leading causes of impaired mobility in the elderly. There is no simple
correlation between pathological changes in the joint and pain severity. No
animal models adequately describe the correlation between joint structure
and symptoms, and very few have properly examined mechanisms of OA
pain generation. We recently reported that, following DMM in the right
knee, C57BL/6 mice develop rapid-onset progressive mechanical allodynia
in the ipsilateral hindpaw only, as early as 2 weeks and developing over
8 weeks post DMM surgery. Adamts5 knockout (KO) mice, which do not
develop OA-like structural changes after DMM, did not develop allodynia.
Our long-term goal is to quantitatively measure pain and dissect molecular
pathways involved in pain generation in a mouse model of OA. We chose
destabilization of the medial meniscus (DMM) in C57BL/6 mice because,
unlike other rodent OA models, the joint pathology in this model is slowly
progressive over 16 weeks and thus optimally suited for studying pain at
different stages of disease.
Methods: DMM surgery was performed in the right knee of 10-week old
male C57BL/6 mice. At different time points after surgery (2, 4, 8, 12 and
16 weeks), pain was assessed in DMM operated mice, in sham controls and
in age-matched naïve controls. Pain-dependent measures included 1) von
Frey analysis to measure mechanical allodynia; and 2) behavioral moni-
toring with Laboras™ equipment, which quantiﬁes activity using pattern
recognition software, including total distance traveled over a speciﬁed time
period. Concurrently, innervating dorsal root ganglia (DRG) L2-L5 were
harvested from both the operated and the non-operated side at different
time points after surgery for RT-PCR analysis. Knee joints were collected
for histopathology or India ink staining.
Results: In the current studies, we found that the unilateral mechanical
allodynia subsided 8-16 weeks after DMM surgery. Total distance traveled
over a speciﬁed period was relatively constant over the ﬁrst 8 weeks after
surgery, but decreased from 12 weeks after surgery. RT-PCR analysis of
innervating DRG at different time points (4, 8, 16 weeks) following DMM
revealed signiﬁcantly increased levels of mRNA (compared to naïve age-
matched controls) for the neurotrophic factors, NGF (nerve growth factor)
and GDNF (glial cell-derived neurotrophic factor), and for the chemokine,
MCP-1 at the 8-week time point. mRNA levels were elevated in both the
ipsi- and in the contralateral DRG (but more so in the ipsilateral DRG).
mRNA levels for substance P or for the NGF receptor, TrkA, were not
elevated (Figure 1). mRNA levels for the genes studied were not elevated in
Adamts5 KO mice.
Figure 1
Conclusions: Time-course experiments in the murine DMM model of OA
enable us to quantify pain at different stages of disease. Pain-related
outcome measures in the DMM model can essentially be divided into an
early stage (wk 2-8, allodynia only) and a late stage (wk 8-16, resolution
of allodynia and appearance of reduced locomotion). Increased mRNA
levels for neurotrophic factors and for MCP-1 in the innervating DRG
were detectable 8 weeks after surgery. These observations suggest that
the DMM model is suitable for studying mechanisms of chronic OA pain
generation.
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RUNT-RELATED TRANSCRIPTION FACTOR 2 ALLELES AND KNEE
CARTILAGE LESIONS ARE ASSOCIATEDWITH INCREASES IN KNEE PAIN
OVER 5 YEARS IN OLD ADULTS
C. Ding1, A. Stephens2, F. Cicuttini3, N. Morrison2, G. Jones1
1Univ. of Tasmania, Hobart, Australia; 2Griﬃth Univ. Gold Coast Campus, Gold
Coast, Australia; 3Monash Univ., Melbourne, Australia
Purpose: Runt-related transcription factor 2 (RUNX-2) is the pivotal
transcription factor for chondrocyte hypertrophy. This study aimed to de-
termine if RUNX-2 and knee cartilage lesions were associated with change
in knee pain over 5 years in older adults.
Methods: A total of 755 randomly selected subjects (mean 62 years, range
51-81, 50% female) were studied at baseline, 2.9 and 5 years later. Knee
pain (on ﬂat surface, going up/down stairs, at night, sitting/lying and
standing upright) at baseline and 5 years was assessed using WOMAC.
RUNX-2 alleles (BB, Bb and bb) were genotyped at baseline. Fat-suppressed
MRI of the right knee was performed to determine knee cartilage volume
and defects at baseline and 2.9 years.
Results: In multivariable analysis, RUNX-2 b allele (Bb 11.8% and bb 1.4%)
was associated with a borderline increase in total knee pain score (≥1) (OR
1.89, P=0.06), an increase in knee pain at night (OR 2.61, P=0.012) and an
increase in sitting/lying knee pain (2.51, P=0.028) over 5 years. Increase in
total knee pain score over 5 years was associated with female sex (OR 2.2,
P=0.03), body mass index (OR 1.07 per kg/m2, P=0.004), knee radiographic
osteoarthritis (OR 2.03 per grade, P=0.006), medial tibiofemoral cartilage
defects (OR 1.46 per grade, P=0.006), lateral tibiofemoral cartilage defects
(OR 1.38 per grade, P=0.025), change in medial cartilage defects over 2.9
years (OR 1.68 per grade, P=0.004) and loss of medial tibial cartilage volume
over 2.9 years (OR 1.07 per percent loss, P=0.03).
Conclusions: Multiple factors contribute to an increase in knee pain over 5
years. This is the ﬁrst study to report that the RUNX-2 b allele predicts in-
creased knee pain. Cartilage lesions are related to knee pain, independently
of potential confounders.
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THE CATHEPSIN K INHIBITOR AZ12606133 REDUCES ARTICULAR
CARTILAGE BREAKDOWN AND JOINT PAIN IN OSTEOARTHRITIC KNEES
J.J. McDougall1, N. Schuelert1, J. Bowyer2
1Univ. of Calgary, Calgary, AB, Canada; 2AstraZeneca, Loughborough, United
Kingdom
Purpose: The aim of the present study was to evaluate the chondropro-
tective and pain modulating effects of a novel cathepsin K inhibitor
AZ12606133 in the Dunkin-Hartley guinea pig model of spontaneous
osteoarthritis (OA).
Methods: Nineteen mature (9 month old) Dunkin Hartley guinea pigs were
chronically implanted with an Alzet osmotic pump (2.5μl/hr; total volume =
2ml) which was set to deliver either the cathepsin K inhibitor AZ12606133
(0.5μg/kg/day, n=10) or vehicle (n=9). On day 28 of treatment, urine was
collected over a 6 hour period by placing guinea pigs in metabolism cages.
The urine was stored at -20[[Unsupported Character - &#61616;]]C until
later analysed for evidence of cartilage degradation using the cross-linked
C-telopeptides of type II (CTXII) collagen assay. Animals were then prepared
for electrophysiological recording of knee joint primary afferent nerves.
Recordings from mechanosensory nerves were made at rest (spontaneous
activity) and in response to rotation of the knee either in the normal
working range (40mNm) or the noxious range (60mNm).
Results: AZ12606133 caused a 63% reduction in urinary CTXII levels com-
pared to vehicle treated guinea pigs (Figure A). Spontaneous afferent ﬁring
rate in vehicle-treated animals was 52.9±14 action potentials/min (n = 26
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ﬁbres) compared to only 8.8±4 action potentials/min (n = 18 ﬁbres) in the
AZ12606133 treated cohort (Figure B). Movement-evoked nerve ﬁring in
AZ12606133 treated animals was approximately 50% of the control group.
Conclusions: Chronic treatment of OA animals with AZ12606133 caused
a reduction in articular cartilage destruction as well as attenuating joint
nociception. It is possible, therefore, that chondroprotection can have
beneﬁcial effects on OA pain severity.
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MMP-13 INHIBITORS REDUCE NOCICEPTION IN A RAT MODEL OF
OSTEOARTHRITIS
R.A. Black1, C. Gabel1, S. Lively2, M. Toteva2, P. Fan2, J. Tocker1, J. Hulme1,
A. Bendele3, R. Whiteside4, J. Henry5
1Amgen, Seattle, WA; 2Amgen, San Francisco, CA; 3Bolder BioPATH, Boulder,
CO; 4Arthroteq Preclinical Services, Toronto, ON, Canada; 5McMaster Univ.,
Hamilton, ON, Canada
Purpose: MMP-13 is a major collagenase in osteoarthritic cartilage, and
speciﬁc inhibitors of it reduce structural deterioration in animal models
of osteoarthritis. Broad-spectrum MMP inhibitors reduce pain behavior
as well as structural damage in such models, apparently by independent
mechanisms. The purpose of the present study was to determine whether
MMP-13-speciﬁc inhibitors affect pain behavior in rats following anterior
cruciate ligament transection (ACLT), and if so, to begin assessing possible
mechanisms of action.
Methods: Three MMP-13 inhibitors were tested, with IC50’s against the
rat enzyme of 41 (compound A), 7 (compound B), and 4 nM (compound
C). All three are at least a thousand-fold less potent against MMPs 1, 2,
3, 8, 9,12, and 14, and all three were negative in assays for inhibition of
COX-1 and COX-2. Sprague-Dawley rats were subjected to ACLT in the right
knee. The rats were then divided into ﬁve groups of 12, 10 of which were
used for sensory testing. The groups were dosed orally, b.i.d., beginning the
day of surgery, with: vehicle, compound A (60 mg/kg), compound B (30
mg/kg), compound C (30 mg/kg), or meloxicam (a commercially available
cyclo-oxygenase inhibitor) (0.5 mg/kg). Laboratory personnel were blinded
with respect to compound identity. Once each week following surgery,
for 4 weeks, the rats were tested for “use-induced” pain: The length of
time required for a tail-ﬂick response to a high-intensity beam of light
was determined before and 1, 3 and 6 minutes after repetitive ﬂexion
and extension of the right knee. A reduction in the time-to-tail-ﬂick is
assumed to reﬂect pain in the agitated joint. After the ﬁnal set of these
measurements, serum was taken to determine drug levels and the joints
were taken for histological analysis.
Inin vitro experiments, cleavage of pro-IL-1β was detected by western blot
and IL-1 activity was determined using Jurkat cells transfected with the
IL-1 receptor and a luciferase reporter.
Results: With vehicle-treated rats, joint agitation decreased the time-to-
tail-ﬂick at all test times. By the fourth week of the study, all three
MMP-13 inhibitors completely eliminated this decrease, as did meloxicam.
In the ﬁrst week, only meloxicam was clearly effective. Compound C was
fully effective by the second week, compound B by the third week, and
compound A not until the fourth week. The compound that acted most
quickly, compound C, was the most potent against MMP-13 and showed
the highest serum concentration at the time of sampling. The histological
analysis revealed little loss of collagen in this experiment. IL-1β is a known
inducer of pain, and in in vitro experiments, MMP-13 was found to generate
active IL-1β from the precursor.
Conclusions: Inhibiting MMP-13 reduced the pro-nociceptive effects of
repetitive ﬂexion and extension of the knee in the rat ACLT model of
osteoarthritis. Other MMPs have been reported to induce pain by activating
IL-1β, and we found that MMP-13, too, can generate an active form of this
cytokine.
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PARTIAL JOINT IMMOBILISATION PROTECTS AGAINST OA AND REVEALS
DISTINCT BIOMECHANICAL THRESHOLDS IN THE JOINT
A. Burleigh, K. Chong, J. Saklatvala, T.L. Vincent
Kennedy Inst. of Rheumatology, London, United Kingdom
Purpose: The role of mechanical factors in OA is undisputed, but how these
factors drive the processes that lead to joint disease is unknown. What
has emerged in recent years is that OA is not simply a disease of cartilage
attrition as a result of abnormal or repetitive wearing of the surfaces, but it
requires activation of pathways that lead to expression of proteases which
degrade the matrix. We used a surgical model of murine OA, induced
by destabilisation of the medial meniscus (DMM) to examine the early
expression of inﬂammatory genes in the joints of OA mice and to assess the
inﬂuence of joint loading on gene expression and the development of OA.
Methods: DMM surgery was performed on 10 week old male C57Bl6 mice
or FGF2 null mice by cutting the right menisco-tibial ligament. Some mice
underwent sham surgery where the capsule of the joint was opened but the
menicso-tibial ligament was left intact. The mice were either left for up to
12 weeks and joints sectioned for histological scoring, or had RNA extracted
at early time points post surgery. Microarray analysis was performed and
regulated genes were selected and validated quantitatively by RT-PCR using
Taqman high density microﬂuidic cards. A subtotal reduction in weight
bearing through the ipsilateral hind limb was induced by cutting the sciatic
nerve at the time of DMM surgery. Complete joint immobilisation following
DMM surgery was achieved by prolonged anaesthesia.
Results: Compared to sham operated mice, DMM surgery strongly induced
a number of genes within 6h of surgery. Of these, the chemokine CCL2,
TNF-stimulated gene 6 (TSG-6), IL-6, serum amyloid A (SAA) and arginase
1 were the most highly regulated. Metalloproteinases including ADAMTS4,
ADAMTS5 and MMP3 were also regulated. Mice that had undergone sciatic
neurectomy exhibited abnormal gait; some weight was born through the
limb, but the leg was maintained in full extension and walking was
achieved by ﬂexion at the hip. When DMM surgery was performed at the
same time as sciatic neurectomy the joints showed no evidence of OA even
12 weeks post surgery. Analysis of early gene expression in these animals
revealed a striking abrogation of 70% of the measured genes. Complete
joint immobilisation (by prolonged anaesthesia) following DMM surgery
abrogated all gene responses in the joint. Those genes that were abrogated
by complete immobilisation, but still induced following DMM surgery in
neurectomised mice were shown to be highly FGF2-dependent in vivo.
Conclusions: These data show that there is an early inﬂammatory response
in the joint to DMM surgery which is highly mechanosensitive. The selective
abrogation of genes following partial and complete joint immobilisation
identiﬁes at least two different in vivo mechanical thresholds within the
joint, one of which appears to be mediated by FGF2. We hypothesise that
exceeding these thresholds determines whether protective or degradative
pathways are activated and whether OA develops.
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EFFECTS OF EXERCISE PROGRAM ON PAIN, JOINT STIFFNESS AND
PHYSICAL FUNCTION IN ELDERLY PATIENTS WITH KNEE
OSTEOARTHRITIS. NURSING-BASED VERSUS HOME-BASED EXERCISE
M.M. Espanha1, R. Lago2, M.J. Carvalho3, A.J. Rego4, J. Teles1
1Fac. Human Kinetics-UTL, Lisboa, Portugal; 2ISAVE-Hlth.Sch. of Alto do Ave,
Póvoa de Lanhoso, Portugal; 3Sports Faculty-UP, Porto, Portugal; 4Sports
Faculty, Porto, Portugal
Purpose: Osteoarthritis (OA) is a leading cause of pain and disability in
elderly people. The knee is the most frequently debilitating joint involved,
compromising function and independence. Exercise can be beneﬁcial in
reducing physical and functional problems experienced by people with OA.
Strength and resistance training are potentially relevant to knee OA because
quadriceps weakness has been related to the development and progression
of knee OA and is modiﬁable by training. Therefore, the aims of this study
were to evaluate the effects of a progressive 8 weeks resistance-training
program in subjects with knee OA with respect to pain, joint stiffness and
physical function and to verify if differences exist between exercise done
in group by nursing resident’s subjects (nursing-based) or individually by
subjects living in their own home (home-based).
Methods: Sixty seven subjects (25 men; 42 women) were divided into
two groups: an exercise group (ExG) (n=34), mean (SD) age 75.2 (4.9) yr,
body mass 72.1 (10.7) kg, height 160.9 (8.4) cm, body mass index (IMC)
27.4 (3.6) kg•m-2; and a control group (CG) (n=33), age 74.9 (4.9) yr, body
mass 74.1 (4.9) kg, height 160.4 (9.3) cm, body mass index (IMC) 28.5 (4.5)
kg•m-2. The ExG was divided afterwards in a nursing-based group (n=19;
80.8±6 yr) and a home-based group (n=15; 69.5±3.8 yr). Diagnosis for
knee OA was done according to American College of Rheumatology clinical
and radiological criteria’s. Resistance-training program involved lower ex-
tremity exercises, especially for quadriceps strengthening. The participants
progressed from completing 2 repetitions per session 2 times per week, to
